Ipilimumab/nivolumabMultisystem toxicities: 20 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-88257-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：438 / 438

相关论文

共 50 条

[1] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 20 case reports
Reactions Weekly, 2019, 1773 (1) : 207 - 207
[2] NivolumabMultisystem toxicities: case report
Reactions Weekly, 2020, 1830 (1) : 252 - 252
[3] Ipilimumab/ipilimumab/nivolumabVarious toxicities: 5 case reports
Reactions Weekly, 2022, 1887 (1) : 394 - 394
[4] Ipilimumab/nivolumabVarious toxicities: 7 case reports
Reactions Weekly, 2019, 1773 (1) : 204 - 204
[5] Ipilimumab/nivolumabVarious toxicities: 5 case reports
Reactions Weekly, 2018, 1726 (1) : 217 - 217
[6] Ipilimumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2016, 1622 (1) : 115 - 115
[7] Ipilimumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2016, 1631 (1) : 98 - 98
[8] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 265 - 265
[9] Ipilimumab/nivolumabVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1877 (1) : 206 - 206
[10] Ipilimumab/nivolumabVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1816 (1) : 192 - 192

← 1 2 3 4 5 →